Fang T - Search Results

1

The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.

Cui M, Sun J, Hou J, Fang T, Wang X, Ge C, Zhao F, Chen T, Xie H, Cui Y, Yao M, Li J, Li H. Cui M, et al. Among authors: fang t. Tumour Biol. 2016 Oct;37(10):13521-13531. doi: 10.1007/s13277-016-5215-7. Epub 2016 Jul 28. Tumour Biol. 2016. PMID: 27465557

2

ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma.

Gao L, Ge C, Fang T, Zhao F, Chen T, Yao M, Li J, Li H. Gao L, et al. Among authors: fang t. J Gastroenterol Hepatol. 2015 Feb;30(2):396-404. doi: 10.1111/jgh.12702. J Gastroenterol Hepatol. 2015. PMID: 25090954

3

Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas.

Fang T, Cui M, Sun J, Ge C, Zhao F, Zhang L, Tian H, Zhang L, Chen T, Jiang G, Xie H, Cui Y, Yao M, Li H, Li J. Fang T, et al. Oncotarget. 2015 Jun 30;6(18):16106-19. doi: 10.18632/oncotarget.3867. Oncotarget. 2015. PMID: 25965830 Free PMC article.

4

An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma.

Li M, Zhang L, Ge C, Chen L, Fang T, Li H, Tian H, Liu J, Chen T, Jiang G, Xie H, Cui Y, Yao M, Li J. Li M, et al. Among authors: fang t. Oncotarget. 2015 Sep 22;6(28):25149-60. doi: 10.18632/oncotarget.4438. Oncotarget. 2015. PMID: 26327240 Free PMC article.

5

Rational design of multifunctional small-molecule prodrugs for simultaneous suppression of cancer cell growth and metastasis in vitro and in vivo.

Xie H, Xu X, Chen J, Li L, Wang J, Fang T, Zhou L, Wang H, Zheng S. Xie H, et al. Among authors: fang t. Chem Commun (Camb). 2016 Apr 25;52(32):5601-4. doi: 10.1039/c5cc10367c. Chem Commun (Camb). 2016. PMID: 27027105

6

Precise Engineering of Prodrug Cocktails into Single Polymeric Nanoparticles for Combination Cancer Therapy: Extended and Sequentially Controllable Drug Release.

Wang H, Wu J, Xie K, Fang T, Chen C, Xie H, Zhou L, Zheng S. Wang H, et al. Among authors: fang t. ACS Appl Mater Interfaces. 2017 Mar 29;9(12):10567-10576. doi: 10.1021/acsami.7b01938. Epub 2017 Mar 15. ACS Appl Mater Interfaces. 2017. PMID: 28271714

7

Notch3 functions as a regulator of cell self-renewal by interacting with the β-catenin pathway in hepatocellular carcinoma.

Zhang Q, Lu C, Fang T, Wang Y, Hu W, Qiao J, Liu B, Liu J, Chen N, Li M, Zhu R. Zhang Q, et al. Among authors: fang t. Oncotarget. 2015 Feb 28;6(6):3669-79. doi: 10.18632/oncotarget.2898. Oncotarget. 2015. PMID: 25668819 Free PMC article.

8

CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma.

Dai W, Miao H, Fang S, Fang T, Chen N, Li M. Dai W, et al. Among authors: fang t, fang s. Mol Med Rep. 2016 Aug;14(2):1509-14. doi: 10.3892/mmr.2016.5410. Epub 2016 Jun 17. Mol Med Rep. 2016. PMID: 27314282 Free PMC article.

9

Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors.

Fang T, Dong Y, Zhang X, Xie K, Lin L, Wang H. Fang T, et al. Int J Pharm. 2016 Oct 15;512(1):39-48. doi: 10.1016/j.ijpharm.2016.08.036. Epub 2016 Aug 17. Int J Pharm. 2016. PMID: 27544846

10

Perspective on prenatal polychlorinated biphenyl exposure and the development of the progeny nervous system (Review).

Wang Y, Hu C, Fang T, Jin Y, Wu R. Wang Y, et al. Among authors: fang t. Int J Mol Med. 2021 Aug;48(2):150. doi: 10.3892/ijmm.2021.4983. Epub 2021 Jun 16. Int J Mol Med. 2021. PMID: 34132363 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,325 results

Search Page

Filters